Doulathunnisa Jaffar Ali
Overview
Explore the profile of Doulathunnisa Jaffar Ali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramakrishnan M, Zhou M, Ceasar S, Ali D, Maharajan T, Vinod K, et al.
Plant Cell Rep
. 2023 Oct;
42(12):1845-1873.
PMID: 37792027
This review discusses the epigenetic changes during somatic embryo (SE) development, highlights the genes and miRNAs involved in the transition of somatic cells into SEs as a result of epigenetic...
2.
He C, Ali D, Qi Y, Li Y, Sun B, Liu R, et al.
J Nanobiotechnology
. 2023 May;
21(1):154.
PMID: 37202772
Background: Sorafenib resistance poses therapeutic challenges in HCC treatment, in which cancer stem cells (CSCs) plays a crucial role. CRISPR/Cas9 can be utilized as a potential technique to overcome the...
3.
He C, Ali D, Sun B, Sun B, Xiao Z
Cancer Drug Resist
. 2022 Sep;
5(3):749-761.
PMID: 36176764
Overcoming drug resistance in cancer therapies remains challenging, and the tumor microenvironment plays an important part in it. Microvesicles (MVs) are functional natural carriers of cellular information, participate in intercellular...
4.
He C, Ali D, Aseervatham G S, Sun B, Xiao Z
Pharmacol Res
. 2021 Apr;
169:105609.
PMID: 33852962
Liver cancer is one of the most malignant cancers worldwide with poor prognosis. Intracellular mediators like microvesicles (MVs) and cancer stem cells (CSCs) are considered as potential candidates in liver...
5.
Ali D, He C, Xu H, Kumaravel S, Sun B, Zhou Y, et al.
Life Sci
. 2021 Feb;
271:119149.
PMID: 33549596
Drug resistance in cancer, still poses therapeutic challenges and tumor microenvironment plays a critical role in it. Microvesicles (MVs) are effective transporters of the molecular information between cells and regulate...
6.
He C, Ali D, Li Y, Zhu Y, Sun B, Xiao Z
PeerJ
. 2020 Oct;
8:e9524.
PMID: 33062407
Safe, efficient and cancer cell targeted delivery of CRISPR/Cas9 is important to increase the effectiveness of available cancer treatments. Although cancer derived exosomes offer significant advantages, the fact that it...
7.
He C, Ali D, Xu H, Kumaravel S, Si K, Li Y, et al.
Exp Cell Res
. 2020 May;
392(2):112040.
PMID: 32380039
Safe and efficient intracellular delivery of CRISPR/Cas9 is a key step for effective therapeutic genome editing in a wide range of diseases. This remains challenging due to multiple drawbacks of...
8.
Liang G, Zhu Y, Ali D, Tian T, Xu H, Si K, et al.
J Nanobiotechnology
. 2020 Jan;
18(1):10.
PMID: 31918721
Background: 5-Fluorouracil (5-FU) has been commonly prescribed for patients with colorectal cancer (CRC), but resistance to 5-FU is one of the main reasons for failure in CRC. Recently, microRNAs (miRNAs)...
9.
Rajasimhan N, Jayaraman S, Ali D, Subramanian B
J Indian Prosthodont Soc
. 2019 Oct;
19(4):332-337.
PMID: 31649442
Aim: To assess the cytotoxicity level of newly introduced poly vinyl ether silicone (PVES) compared to poly vinyl siloxane (PVS) and polyether (PE) elastomeric impression materials. Settings And Design: Comparative...
10.
Zhou Y, Tian T, Zhu Y, Ali D, Hu F, Qi Y, et al.
J Cell Biochem
. 2017 Apr;
118(12):4267-4274.
PMID: 28422319
Exosomes, the natural vehicles of intercellular communication, transfer proteins, mRNAs, and microRNAs (miRNAs) and mediate many physiological and pathological processes. It is not clear that whether exosomal miRNAs could regulate...